{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:01:46Z","timestamp":1780603306204,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130120"],"award-info":[{"award-number":["82130120"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474045"],"award-info":[{"award-number":["82474045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19401972700"],"award-info":[{"award-number":["19401972700"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.joim.2026.03.003","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T08:08:52Z","timestamp":1773302932000},"page":"365-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Yinchenhao Decoction, a compound Chinese herbal medicine, for patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"24","author":[{"given":"Fei-peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-hai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-yu","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-lan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.joim.2026.03.003_b0005","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.joim.2026.03.003_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/TP.0000000000002466","article-title":"Steatosis in liver transplantation: current limitations and future strategies","volume":"103","author":"Linares","year":"2019","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.joim.2026.03.003_b0025","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/oby.22964","article-title":"A fad too far? Dietary strategies for the prevention and treatment of NAFLD","volume":"28","author":"Moore","year":"2020","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"10.1016\/j.joim.2026.03.003_b0030","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/ptr.6972","article-title":"Effect of Portulaca oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"35","author":"Darvish Damavandi","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.joim.2026.03.003_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105465","article-title":"Effect of Portulaca oleracea (purslane) extract on inflammatory factors in nonalcoholic fatty liver disease: a randomized, double-blind clinical trial","volume":"102","author":"Darvish Damavandi","year":"2023","journal-title":"J Funct Foods"},{"issue":"3","key":"10.1016\/j.joim.2026.03.003_b0040","first-page":"221","article-title":"The association between food insulin index and odds of non-alcoholic fatty liver disease (NAFLD) in adults: a case-control study","volume":"14","author":"Fatahi","year":"2021","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/ptr.8404","article-title":"Effect of pomegranate peel consumption on liver enzymes, lipid profile, liver steatosis, and Hs-CRP in patients with non-alcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"39","author":"Baghdadi","year":"2025","journal-title":"Phytother Res"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/07315724.2018.1479990","article-title":"Effect of soy milk on metabolic status of patients with nonalcoholic fatty liver disease: a randomized clinical trial","volume":"38","author":"Eslami","year":"2019","journal-title":"J Am Coll Nutr"},{"issue":"4","key":"10.1016\/j.joim.2026.03.003_b0055","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/jsfa.10215","article-title":"The effects of hydroalcoholic extract of spinach on prevention and treatment of some metabolic and histologic features in a rat model of nonalcoholic fatty liver disease","volume":"100","author":"Amirinejad","year":"2020","journal-title":"J Sci Food Agric"},{"key":"10.1016\/j.joim.2026.03.003_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1087260","article-title":"Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Rong","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.joim.2026.03.003_b0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJMe2314365","article-title":"Selective agonists of thyroid hormone receptor \u03b2 for the treatment of NASH","volume":"390","author":"Cusi","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joim.2026.03.003_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.771459","article-title":"The potential application of Chinese medicine in liver diseases: a new opportunity","volume":"12","author":"Fu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.joim.2026.03.003_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117514","article-title":"Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease","volume":"321","author":"Xu","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"10.1016\/j.joim.2026.03.003_b0085","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jtcme.2023.02.010","article-title":"Yinchenhao Tang alleviates high fat diet induced NAFLD by increasing NR1H4 and APOA1 expression","volume":"13","author":"Xu","year":"2023","journal-title":"J Tradit Complement Med"},{"issue":"3","key":"10.1016\/j.joim.2026.03.003_b0090","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0254-6272(11)60045-9","article-title":"Effects of Yinchenhao decoction (see text) for non-alcoholic steatohepatitis in rats and study of the mechanism","volume":"31","author":"Chen","year":"2011","journal-title":"J Tradit Chin Med"},{"issue":"4","key":"10.1016\/j.joim.2026.03.003_b0095","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","article-title":"Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis","volume":"57","author":"Bechmann","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.joim.2026.03.003_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.164307","article-title":"Bisphenol a induced hepatic steatosis by disturbing bile acid metabolism and FXR\/TGR5 signaling pathways via remodeling the gut microbiota in CD-1 mice","volume":"889","author":"Hong","year":"2023","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.joim.2026.03.003_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2022.111910","article-title":"Plasma phospholipid arachidonic acid in relation to non-alcoholic fatty liver disease: mendelian randomization study","volume":"106","author":"Chen","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/j.joim.2026.03.003_b0115","doi-asserted-by":"crossref","unstructured":"National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association; Fatty Liver Disease Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China). J Dig Dis 2018;20(4):166\u201373.","DOI":"10.1111\/1751-2980.12685"},{"issue":"11","key":"10.1016\/j.joim.2026.03.003_b0120","first-page":"805","article-title":"Consensus guidelines on integrated traditional Chinese and Western medicine for diagnosis and treatment of non-alcoholic fatty liver disease (2017)","volume":"25","author":"Li","year":"2017","journal-title":"Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi"},{"key":"10.1016\/j.joim.2026.03.003_b0125","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4614-0650-1_6","article-title":"Sphingolipids and hepatic steatosis","volume":"721","author":"Bikman","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.joim.2026.03.003_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102596","article-title":"Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis","volume":"59","author":"Alarc\u00f3n-Vila","year":"2023","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.joim.2026.03.003_b0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.joim.2026.03.003_b0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1440-1746.2012.07165.x","article-title":"Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors","volume":"27","author":"Jin","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.joim.2026.03.003_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118649","article-title":"Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier","volume":"335","author":"Zhang","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"Pt A","key":"10.1016\/j.joim.2026.03.003_b0150","article-title":"Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor","volume":"318","author":"Zhang","year":"2024","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0155","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.30254","article-title":"Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.joim.2026.03.003_b0160","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.joim.2026.03.003_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol Metab"},{"issue":"7","key":"10.1016\/j.joim.2026.03.003_b0170","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","article-title":"Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"8","author":"Tincopa","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.joim.2026.03.003_b0175","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0185","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.joim.2026.03.003_b0190","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.21037\/qims-22-393","article-title":"The spectrum of magnetic resonance imaging proton density fat fraction (MRI-PDFF), magnetic resonance spectroscopy (MRS), and two different histopathologic methods (artificial intelligence vs pathologist) in quantifying hepatic steatosis","volume":"12","author":"Kim","year":"2022","journal-title":"Quant Imaging Med Surg"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/apt.17564","article-title":"Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs","volume":"58","author":"Kim","year":"2023","journal-title":"MRI-PDFF in NAFLD Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.joim.2026.03.003_b0200","first-page":"500","article-title":"Distribution characteristics of TCM constitutional types in 141 patients with fatty liver and relationships between these characteristics and syndromes","volume":"33","author":"Wang","year":"2010","journal-title":"Beijing Zhong Yi Yao Da Xue Xue Bao"},{"issue":"6","key":"10.1016\/j.joim.2026.03.003_b0205","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3892\/ijmm_00000412","article-title":"Alleviation of hepatic oxidative stress by Chinese herbal medicine Yin-Chen-Hao-Tang in obese mice with steatosis","volume":"25","author":"Lee","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.joim.2026.03.003_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8917993","article-title":"The study of Yin-Chen-Hao-Tang preventing and treating alcoholic fatty liver disease through PPAR signaling pathway based on network pharmacology and RNA-Seq transcriptomics","volume":"2021","author":"Zhu","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12906-023-03878-0","article-title":"The effects of aqueous and ethanolic extracts of Rheum Ribes on insulin-resistance and apolipoproteins in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"23","author":"Ghafouri","year":"2023","journal-title":"BMC Compl Med Ther"},{"key":"10.1016\/j.joim.2026.03.003_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.hermed.2020.100389","article-title":"The effect of aqueous, ethanolic extracts of Rheum ribeson insulin sensitivity, inflammation, oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial","volume":"24","author":"Ghafouri","year":"2020","journal-title":"J Herb Med"},{"key":"10.1016\/j.joim.2026.03.003_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctcp.2020.101259","article-title":"The effects of sumac (Rhus coriaria L.) powder supplementation in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"41","author":"Kazemi","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"10.1016\/j.joim.2026.03.003_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.hermed.2021.100525","article-title":"Effects of sumac (Rhus coriaria) on lipid profile, leptin and steatosis in patients with non-alcoholic fatty liver disease: a randomized double-blind placebo-controlled trial","volume":"31","author":"Ehsani","year":"2022","journal-title":"J Herb Med"},{"key":"10.1016\/j.joim.2026.03.003_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114732","article-title":"Role of eicosanoids in liver repair, regeneration and cancer","volume":"192","author":"Alvarez","year":"2021","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0240","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/03602532.2013.837916","article-title":"Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids","volume":"46","author":"Shahabi","year":"2014","journal-title":"Drug Metab Rev"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0245","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"10.1016\/j.joim.2026.03.003_b0250","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.3390\/molecules27123873","article-title":"CYP450 epoxygenase metabolites, epoxyeicosatrienoic acids, as novel anti-inflammatory mediators","volume":"27","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.joim.2026.03.003_b0255","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.joim.2026.03.003_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154457","article-title":"Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression","volume":"116","author":"Nimer","year":"2021","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.joim.2026.03.003_b0265","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/hep.32568","article-title":"Metabolic reprogramming of the intestinal microbiome with functional bile acid changes underlie the development of NAFLD","volume":"76","author":"Smirnova","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.joim.2026.03.003_b0270","first-page":"305","article-title":"Absence of intestinal bile promotes bacterial translocation","volume":"58","author":"Slocum","year":"1992","journal-title":"Am Surg"},{"issue":"4","key":"10.1016\/j.joim.2026.03.003_b0275","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/molecules21040435","article-title":"Dietary nucleotides supplementation and liver injury in alcohol-treated rats: a metabolomics investigation","volume":"21","author":"Cai","year":"2016","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.joim.2026.03.003_b0280","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.joim.2026.03.003_b0285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrgastro.2016.167","article-title":"NAFLD: blocking ileal bile acid uptake safeguards against NAFLD","volume":"13","author":"Thomas","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.joim.2026.03.003_b0290","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.joim.2026.03.003_b0295","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12906-015-0627-2","article-title":"Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang","volume":"15","author":"Yang","year":"2015","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0300","article-title":"NASH-related increases in plasma bile acid levels depend on insulin resistance","volume":"3","author":"Grzych","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0305","doi-asserted-by":"crossref","first-page":"15367","DOI":"10.1038\/s41598-018-33669-4","article-title":"Yinchenhao decoction alleviates liver fibrosis by regulating bile acid metabolism and TGF-\u03b2\/Smad\/ERK signalling pathway","volume":"8","author":"Cai","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.joim.2026.03.003_b0310","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","article-title":"Bile salt biotransformations by human intestinal bacteria","volume":"47","author":"Ridlon","year":"2006","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.joim.2026.03.003_b0315","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0039-128X(80)90115-4","article-title":"Bile acid induction specificity of 7 alpha-dehydroxylase activity in an intestinal Eubacterium species","volume":"35","author":"White","year":"1980","journal-title":"Steroids"},{"key":"10.1016\/j.joim.2026.03.003_b0320","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/8882667","article-title":"Yinchenhao decoction protects against acute liver injury in mice with biliary acute pancreatitis by regulating the gut microflora\u2013bile acids\u2013liver axis","volume":"2024","author":"Zhao","year":"2024","journal-title":"Gastroenterol Res Pract"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642600035X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209549642600035X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:33:41Z","timestamp":1780601621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209549642600035X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S209549642600035X"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2026.03.003","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yinchenhao Decoction, a compound Chinese herbal medicine, for patients with nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2026.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Shanghai Yueyang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}